This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Social phobia is a common mental disorder (lifetime prevalence 2.4-13.3%) characterized by a marked and persistent fear of one or more social or performance situations in which a person is exposed to unfamiliar people or to possible scrutiny by others. Both basic science and clinical findings provide evidence for a role of the endogenous opioid system in social phobia. Naloxone, a non-specific opioid receptor antagonist, causes the release of cortisol by antagonizing the tonic opioid inhibitory activity on the CRF releasing neurons of the PVN. Assessment of the cortisol response to naloxone thus provides an estimate of the degree of endogenous opioid system activity at the PVN. This procedure has been utilized in studies of alcoholism, post-traumatic stress disorder, major depression and obsessive compulsive disorder, but has not been evaluated to date in social phobia patients. A genetic component to social phobia is supported by a number of twin studies and familial heritability studies, yet linkage analysis has found no effect of the serotonin transporter, serotonin 2 receptor, dopamine transporter, dopamine 2, 3, and 4 receptor genes. Opioid system genes have not been assessed in social phobia patients. One such gene, OPRM1, has been implicated in differential cortisol response to naloxone The study will employ a placebo-controlled, balanced, within-subject design involving two test days over a 3-7 day period. Fifty subjects (25 subjects with DSM-IV social phobia and 25 age- and sex-matched control subjects) will undergo the pharmacological challenge procedures and genotyping for the Asn40Asp -opioid receptor polymorphism. On each test day subjects will receive either naloxone or placebo, in random order, separated by at least 3 days. Self-report measures, vital signs (including blood pressure, pulse, and temperature), and serum cortisol and ACTH samples will be obtained at -15 minutes, at baseline, and at 15, 30, 45, 60, 75, and 90 minutes following the infusion. The results of this study will illuminate components of the underlying pathophysiology of social phobia, and contribute to the potential development of future pharmacologic treatments based on the endogenous opioid system.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR006192-13
Application #
7377315
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2006-04-01
Project End
2007-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
13
Fiscal Year
2006
Total Cost
$867
Indirect Cost
Name
University of Connecticut
Department
Type
Schools of Medicine
DUNS #
022254226
City
Farmington
State
CT
Country
United States
Zip Code
Lieberman, Richard; Kranzler, Henry R; Levine, Eric S et al. (2018) Examining the effects of alcohol on GABAA receptor mRNA expression and function in neural cultures generated from control and alcohol dependent donor induced pluripotent stem cells. Alcohol 66:45-53
Usmani, Saad; Choquette, Linda; Bona, Robert et al. (2018) Transient bacteremia induced by dental cleaning is not associated with infection of central venous catheters in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 125:286-294
Moscufo, Nicola; Wakefield, Dorothy B; Meier, Dominik S et al. (2018) Longitudinal microstructural changes of cerebral white matter and their association with mobility performance in older persons. PLoS One 13:e0194051
Santos-Cortez, Regie Lyn P; Hu, Ying; Sun, Fanyue et al. (2017) Identification of ASAH1 as a susceptibility gene for familial keloids. Eur J Hum Genet 25:1155-1161
Jin, Lingling; Liu, Yi; Sun, Fanyue et al. (2017) Three novel ANO5 missense mutations in Caucasian and Chinese families and sporadic cases with gnathodiaphyseal dysplasia. Sci Rep 7:40935
Lieberman, Richard; Kranzler, Henry R; Levine, Eric S et al. (2017) Examining FKBP5 mRNA expression in human iPSC-derived neural cells. Psychiatry Res 247:172-181
Walter, Kimberly N; Petry, Nancy M (2016) Lifetime suicide attempt history, quality of life, and objective functioning among HIV/AIDS patients with alcohol and illicit substance use disorders. Int J STD AIDS 27:476-85
Litt, Mark D; Kadden, Ronald M; Tennen, Howard et al. (2016) Network Support II: Randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug Alcohol Depend 165:203-12
Sullivan, Tami P; Weiss, Nicole H; Flanagan, Julianne C et al. (2016) PTSD and Daily Co-Occurrence of Drug and Alcohol Use Among Women Experiencing Intimate Partner Violence. J Dual Diagn 12:36-42
Liu, Yaling; Dutra, Eliane H; Reichenberger, Ernst J et al. (2016) Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia. J Negat Results Biomed 15:18

Showing the most recent 10 out of 638 publications